Completed PHASE2 INTERVENTIONAL 2-arm NCT06256926

A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

A Prospective, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Curcuvail® of K Patel Phyto Extractions Pvt. Ltd. in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Sponsor: COD Research Private Ltd

Conditions Fatty Liver Without Mention of Alcohol

Interventions Placebo product Test Product: Curcuvail® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids)

Updated 3 times since 2024 Last updated: Feb 5, 2024 Started: Jan 8, 2021 Primary completion: Nov 25, 2021 Completion: Nov 25, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Fatty Liver Without Mention of Alcohol and is currently completed. COD Research Private Ltd leads this study, which shows 3 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2024 — Jul 2024 [monthly]

Completed PHASE2

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

COD Research Private Ltd

Data source: COD Research Private Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ahmedabad, India